Bioequivalance study of Famotidine 40 mg
Not Applicable
- Conditions
- Subject: Bioequivalence of Famotidine 40 mg Tablet and Comparison of Pharmacokinetic Parameters with Ratiopham Reference Tablet.
- Registration Number
- IRCT20200513047423N9
- Lead Sponsor
- Iran Daru Pharmaceutical Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Healthy liver
Healthy kidney
Volunteers should not be too fat or too thin and their weight index should be in the appropriate range
Exclusion Criteria
Out of age ranges
smoking
pragnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method